Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells. In vitro and in vivo studies of a drug-lipoprotein complex.

[1]  J. Cornet,et al.  Vinblastine-C4 alkyl maleoyl and amino acid maleoyl derivatives: III. Experimental antitumor activities of lactosaminated serum albumin conjugates. , 1989, Anticancer research.

[2]  E. Huehns,et al.  Specific targeting and toxicity of sulphonated aluminium phthalocyanine photosensitised liposomes directed to cells by monoclonal antibody in vitro. , 1989, British Journal of Cancer.

[3]  G. Eisenbrand,et al.  Nitrosoureas. Modes of action and perspectives in the use of hormone receptor affinity carrier molecules. , 1989, Acta oncologica.

[4]  B Lundberg,et al.  Preparation of drug-low density lipoprotein complexes for delivery of antitumoral drugs via the low density lipoprotein pathway. , 1987, Cancer research.

[5]  H. Ginsberg,et al.  Hypocholesterolemia and acute myelogenous leukemia: Association between disease activity and plasma low‐density lipoprotein cholesterol concentrations , 1986, Cancer.

[6]  S. Vitols,et al.  Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice. , 1986, Cancer research.

[7]  S. Vitols,et al.  Selective uptake of a toxic lipophilic anthracycline derivative by the low-density lipoprotein receptor pathway in cultured fibroblasts. , 1985, Journal of medicinal chemistry.

[8]  G. Canti,et al.  In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour line in mice. , 1984, Cancer letters.

[9]  G. Gahrton,et al.  Elevated low density lipoprotein receptor activity in leukemic cells with monocytic differentiation. , 1984, Blood.

[10]  G. Gahrton,et al.  Significance of the low-density lipoprotein (LDL) receptor pathway for the in vitro accumulation of AD-32 incorporated into LDL in normal and leukemic white blood cells. , 1984, Cancer treatment reports.

[11]  S. Yanovich,et al.  Preparation and interaction of a low-density lipoprotein:daunomycin complex with P388 leukemic cells. , 1984, Cancer research.

[12]  E. Simpson,et al.  Low-density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms. , 1981, American journal of obstetrics and gynecology.

[13]  Y. Kaneko.  Thyrotropin-Daunomycin Conjugate Shows Receptor-Mediated Cytotoxicity in Cultured Thyroid Cells , 1981, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[14]  M. Krieger,et al.  Reconstituted low density lipoprotein: a vehicle for the delivery of hydrophobic fluorescent probes to cells. , 1979, Journal of supramolecular structure.

[15]  R. Mahley,et al.  Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. , 1978, The Journal of biological chemistry.

[16]  M. Brown,et al.  Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. , 1978, Blood.

[17]  M. Brown,et al.  The low-density lipoprotein pathway and its relation to atherosclerosis. , 1977, Annual review of biochemistry.

[18]  G. Gregoriadis.  The Carrier Potential of Liposomes in Biology and Medicine , 1976 .

[19]  G Gregoriadis,et al.  The carrier potential of liposomes in biology and medicine (second of two parts). , 1976, The New England journal of medicine.

[20]  R. Levy,et al.  The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities. , 1975, Cancer research.

[21]  C. Duve,et al.  Chemotherapy through lysosomes with a DNA-daunorubicin complex. , 1972, Nature: New biology.

[22]  R. Levy,et al.  The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. , 1972, The Journal of clinical investigation.

[23]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[24]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.